Portuguese point-of-care diagnostics company biosurfit has gained CE-mark approval for its HbA1c clinical blood test to assist doctors diagnose diabetes. The three-in-one haematology/immunoassays/clinical chemistry test is designed to identify patients who may be at risk for developing diabetes.
HbA1c tests are one of the most common diagnostic tools to diagnose diabetes, and biosurfit's test is designed to make blood testing more convenient and comprehensive with its three-in-one capabilities....